MedPath

Marley Spoon SE

Ownership
-
Employees
1.4K
Market Cap
-
Website
Introduction

Minco Capital Corp is focused on utilizing its working capital position, industry contacts and internal expertise to identify, evaluate and invest in assets that have the capacity to generate returns and growth. The company invests in publicly traded and privately held corporations as well as taking indirect and direct ownership stakes in resource projects. Its types of investments may include common shares, preferred shares, warrants, royalties, convertible debentures, bridge loans, and other investment vehicles. It has one segment which is the acquisition and sale of investments in other companies.

Clinical Trials

30

Active:1
Completed:15

Trial Phases

3 Phases

Phase 3:1
Phase 4:2
Not Applicable:21

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials

Not Applicable
21 (87.5%)
Phase 4
2 (8.3%)
Phase 3
1 (4.2%)

Digital Bonding vs. Direct Bonding Study

Not Applicable
Conditions
Orthodontic Brackets
First Posted Date
2024-02-20
Last Posted Date
2025-04-17
Lead Sponsor
3M
Target Recruit Count
178
Registration Number
NCT06266130
Locations
🇺🇸

The Orthodontic Studio, Glendale, California, United States

🇺🇸

Nadeau Orthodontics, Kennebunk, Maine, United States

🇺🇸

Northwell Health Physician Partners Dental Medicine at Great Neck, Great Neck, New York, United States

and more 2 locations

Evaluating the Efficacy and Safety of the VERAFLO™ Dressing Kit for Wound Bed Preparation in Open Wounds

Not Applicable
Completed
Conditions
Wound Healing
First Posted Date
2023-06-15
Last Posted Date
2025-03-11
Lead Sponsor
KCI USA, Inc
Target Recruit Count
170
Registration Number
NCT05902793
Locations
🇨🇳

Anhui Provincial Hospital, Hefei, Anhui, China

🇨🇳

Foshan Hospital of TCM, Foshan, Guangdong, China

🇨🇳

Xi'an Honghui Hospital, Xi'an, Shanxi, China

and more 1 locations

[Trial of device that is not approved or cleared by the U.S. FDA]

Not Applicable
First Posted Date
2022-11-14
Last Posted Date
2025-05-06
Lead Sponsor
[Redacted]
Target Recruit Count
353
Registration Number
NCT05614869

Scotchbond Universal Plus Compared to Scotchbond Universal With Filtek Universal Restorative to Restore Class V NCCLs

Not Applicable
Active, not recruiting
Conditions
Class V Non-carious Cervical Dental Lesions
First Posted Date
2022-05-05
Last Posted Date
2023-10-12
Lead Sponsor
3M
Target Recruit Count
38
Registration Number
NCT05361746
Locations
🇺🇸

Louisiana State University HSC-Health, School of Dentistry, New Orleans, Louisiana, United States

Scotchbond Universal Plus Compared to Scotchbond Universal for Posterior Class I & II Restorations With Filtek Universal

Not Applicable
Completed
Conditions
Dental Decay
Cavities of Teeth
First Posted Date
2022-02-21
Last Posted Date
2025-06-12
Lead Sponsor
3M
Target Recruit Count
51
Registration Number
NCT05248204
Locations
🇺🇸

University of Minnesota School of Dentristry, Minneapolis, Minnesota, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

Needle-Free Drug Delivery Devices Market Set to Reach $5+ Billion by 2035

The needle-free injection system market is projected to grow at a CAGR of 4% from $606 million in 2024 to 2035, driven by increasing chronic disease prevalence and patient preference for painless administration.

New Report Reveals Critical Insights into Clinical-Stage Pharma Partnerships from 2020-2025

A comprehensive new industry report analyzes over 1,670 clinical-stage partnering agreements in pharma and biotech from 2020-2025, providing unprecedented access to deal structures and financial terms.

© Copyright 2025. All Rights Reserved by MedPath